Skip to main content

Table 3 SIBO rate in Chinese IBS-D patients pre- and post- rifaximin treatment

From: Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome

 

LHBT

95% CI (%)

P value

 

Positive/N (%)

Negative/N (%)

Pre-treatment

45 (57.7)

33 (42.3)

46.5–68.9

<0.001

Post-treatment

25 (32.1)

53 (67.9)

21.5–42.6

  1. Note: SIBO, Small intestinal bacterial overgrowth; IBS, Irritable bowel syndrome; IBS-D, diarrhea-predominant IBS
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us